INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

21,588 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

11
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$213K
1,985 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

11
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,541 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

10
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$41K
6,959 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

10
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$30K
1,344 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
891 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$2,677
63 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$6,160
145 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$4,078
96 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$5,030
124 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
509 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$7,211
179 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$5,184
127 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

7
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$12K
194 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

5
SG
Steele Richard GSVP - General Counsel
MCOMOODYS CORP /DE/
Open-market sale · 10b5-1 plan
SELL$15K
34 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MA
Majalya Sidney A.SVP, CLO and Secretary
TNETTRINET GROUP, INC.
Open-market sale · 10b5-1 plan
SELL$29K
775 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
952 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$211K
1,048 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$1.40M
1.04M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

47
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$576K
430.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

43
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$414K
308.8K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

26
MM
Mindlin Damian MiguelVice President
PAMPampa Energy Inc.
Open-market sale
SELL$1.78M
500.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

26
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$332K
11.4K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

24
PE
Perros EvangelosChief Financial Officer
PGYPagaya Technologies Ltd.
Open-market sale
SELL$147K
13.0K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

23
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
3,348 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

22
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.90M
49.3K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

22
RV
Raghunathan VivekSVP, Engineering
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$592K
3,876 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

21
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$2,160
61.7K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

21
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$1,500
50.0K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

20
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,320
300 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

17
BM
Beneski Benjamin MachinasSVP, Chief Technical Officer
ALLOAllogene Therapeutics, Inc.
Open-market sale
SELL$7,168
2,867 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

15
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
2,200 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

13
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
668 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

8
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,101
300 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$32K
1,416 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

51
ZR
Zagari RaffaeleDirector
SBLKStar Bulk Carriers Corp.
Open-market sale
SELL$2.62B
11.5K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

Page 344 of 540
← PrevNext →